noscript

News and Announcements

Revolutionary New Arthritis Treatment from Jardine Pharmaceuticals

  • Published April 09, 2015 10:46AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

There is a basic human desire to relieve pain and prolong life, which fuels the search for effective medications. Most drugs come from nature and more than half of the world’s population still rely entirely on plants for their medicines.

Oak is used traditionally for treatment of arthritis. Pharmaceutical efficacy is now achieved through a proprietary extraction process for oak, beating arthritis drugs. The TGA listed oak Polypill™ capsules will be launched through existing distribution networks (Q4 2014).

Jardine Pharmaceuticals has the exclusive worldwide licence for modified polyphenol oak extracts in a complementary medicine format.

Jardine Pharmaceuticals is raising capital to fund further product/market development and research.

Yesterday, Jardine Pharmaceuticals were featured on Current Affair. To watch the video, please click the image below. 

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now